Neuberger Berman Group
SRNE

Neuberger Berman Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Neuberger Berman Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-44,200
Closed -$566K – 1761
2014
Q1 		$566K Buy
+44,200
New +$566K ﹤0.01% 1317